Looking for Dextrose Monohydrate pharmaceutical excipients? Find information on Dextrose Monohydrate's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: D glucose monohydrate, Dextrose monohydrate excipient
Dextrose Monohydrate is the monohydrate form of D-glucose, a natural monosaccharide and carbohydrate. Dextrose serves to replenish lost nutrients and electrolytes. The agent provides metabolic energy and is the primary ingredient in oral rehydration salts (ORS) and is used in intravenous (IV) fluids to provide nutrients to patients under intensive care who are unable to receive them by the oral route. Solutions containing dextrose restore blood glucose levels, provide calories, may aid in minimizing liver glycogen depletion and exerts a protein-sparing action. Dextrose also plays a role in the production of proteins and in lipid metabolism.

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDA Dossiers

read-more
read-more

01

Dosage Form : INJECTABLE

DEXTROSE MONOHYDRATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : INJECTABLE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : INTRAVENOUS

CAS : 77938637

UNII : LX22YL083G

Potency Amount : 5

Potency Unit : %

blank

02

Dosage Form : INJECTION

DEXTROSE MONOHYDRATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : INJECTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : INTRAVENOUS

CAS : 77938637

UNII : LX22YL083G

Potency Amount : 5.05

Potency Unit : %

blank

03

Dosage Form : SOLUTION, INJECTION

DEXTROSE MONOHYDRATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SOLUTION, INJECTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : INTRAVENOUS

CAS : 77938637

UNII : LX22YL083G

Potency Amount : 5

Potency Unit : %

blank

04

Dosage Form : SPRAY, METERED

DEXTROSE MONOHYDRATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SPRAY, METERED

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : NASAL

CAS : 77938637

UNII : LX22YL083G

Potency Amount : 5.5

Potency Unit : %

blank

05

Dosage Form : SUSPENSION

DEXTROSE MONOHYDRATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : NASAL

CAS : 77938637

UNII : LX22YL083G

Potency Amount : 0

Potency Unit : NA

blank

06

Dosage Form : TABLET, EXTENDED RELEASE

DEXTROSE MONOHYDRATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : TABLET, EXTENDED RELEASE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 77938637

UNII : LX22YL083G

Potency Amount : 46.2

Potency Unit : MG

blank

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Fillers Diluents Binders

read-more
read-more

Parenteral

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

MARKET PLACE

Do you need sourcing support? Ask us
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty